Intellia Therapeutics (NTLA) stock fell ~9% in reaction to Phase 2 trial data for a CRISPR-based gene editing therapy for ...

Intellia Therapeutics has taken another step toward its goal of winning the first approval for an in vivo CRISPR therapy, ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

Find Latest News, Videos and Pictures about CRISPR. Explore latest updates, news, information from NewsBytes. All about CRISPR.

When the scientists used CRISPR to edit out these genes, blood stem cells reversed their natural tendency and produced more innate immune cells instead of adaptive immune cells-;like in the early ...

What keeps some immune systems youthful and effective in warding off age-related diseases? In new research done on mice, scientists point the finger at a small subset of blood stem cells, which make ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...

We took a look around the SfN 2024 poster hall, picking our favorite posters and those we thought our audience would be most ...

Charting the "dark matter" of the viral universe has implications not just for biotechnology—but potentially for battling the ...